Preferred Name |
Ergotamine |
|
Synonyms |
ERGOTAMINE Ergotamine |
|
Definitions |
A naturally occurring ergot alkaloid with vasoconstrictor and analgesic property. Ergotamine selectively binds and activates serotonin (5-HT) 1D receptors located on intracranial blood vessels, including those on arterio-venous anastomoses, thereby resulting in vasoconstriction and reducing the blood flow in cerebral arteries that may lead to relieve of vascular headaches. This agent also selectively binds to alpha-adrenergic receptors, thereby stimulating vascular smooth muscle and causing vasoconstriction in both arteries and veins, which also contributes to the relief of headaches. Furthermore, the activation of 5-HT1D receptors on sensory nerve endings of the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C61751 |
|
CAS_Registry |
113-15-5 |
|
CHEBI_ID |
CHEBI:64318 |
|
Chemical_Formula |
C33H35N5O5 |
|
code |
C61751 |
|
Concept_In_Subset | ||
Contributing_Source |
FDA |
|
DEFINITION |
A naturally occurring ergot alkaloid with vasoconstrictor and analgesic property. Ergotamine selectively binds and activates serotonin (5-HT) 1D receptors located on intracranial blood vessels, including those on arterio-venous anastomoses, thereby resulting in vasoconstriction and reducing the blood flow in cerebral arteries that may lead to relieve of vascular headaches. This agent also selectively binds to alpha-adrenergic receptors, thereby stimulating vascular smooth muscle and causing vasoconstriction in both arteries and veins, which also contributes to the relief of headaches. Furthermore, the activation of 5-HT1D receptors on sensory nerve endings of the trigeminal system results in the inhibition of pro-inflammatory neuropeptide release. |
|
FDA_UNII_Code |
PR834Q503T |
|
FULL_SYN |
ERGOTAMINE Ergotamine |
|
Has_Salt_Form | ||
label |
Ergotamine |
|
Legacy Concept Name |
Ergotamine |
|
Preferred_Name |
Ergotamine |
|
prefixIRI |
Thesaurus:C61751 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0014710 |
|
subClassOf |